# 24-Hour Intraocular Pressure Control With Bimatoprost/Timolol Versus Latanoprost as First Choice

> **NCT01448837** · PHASE4 · COMPLETED · sponsor: **Aristotle University Of Thessaloniki** · enrollment: 37 (actual)

## Conditions studied

- Glaucoma

## Interventions

- **DRUG:** Bimatoprost/Timolol, 24-hour intraocular pressure monitoring
- **DRUG:** Latanoprost, 24-hour intraocular pressure monitoring

## Key facts

- **NCT ID:** NCT01448837
- **Lead sponsor:** Aristotle University Of Thessaloniki
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2014-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01448837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01448837, "24-Hour Intraocular Pressure Control With Bimatoprost/Timolol Versus Latanoprost as First Choice". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT01448837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*